The Neuspera percutaneous sacral neuromodulation (pSNM ... The primary safety end point is the incidence of device-related serious adverse events at 6 months. Secondary end points include those ...

gmail.com Objective To assess whether there was any relationship between the number of clinical markers for spinal dysraphism and its presence on ultrasound and whether there was any relationship ...

A week ago, the incidence had been at 511.5. In a comparison of the federal states, only Bremen has a higher seven-day incidence than Berlin. Not included in the Berlin figures are data from ...